From Beth Lewin Dean, CEO <[email protected]>
Subject Researching to CURE Epilepsy: Spring 2022
Date May 12, 2022 4:02 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
See the impact we have had on the epilepsy community.

[link removed]
Dear Friend of CURE Epilepsy,
We are excited to share the Spring 2022 CURE Epilepsy report, ReSearching to CURE Epilepsy ([link removed]) with our community. We are sharing this as a reminder of how important you are to making our work possible. The report highlights the latest discoveries, partnerships, and people who have made extraordinary breakthroughs in epilepsy research, as well as those living with epilepsy who have inspired us to continue our crucial work.
Read the Report ([link removed])

In this edition, we showcase CURE Epilepsy’s pioneering role in Sudden Unexpected Death in Epilepsy (SUDEP) research and our legacy of leadership. Featured stories include:
* Jeanne Donalty's mission to bring awareness to SUDEP in honor of her son Christopher. Her efforts led to a two-decade-long journey of advocacy for SUDEP research and conversations.

* Dr. Peter Carlen's amazing 20+ years career in epilepsy research, beginning as a CURE Epilepsy grantee whose investigative study laid the foundation for further research into seizure detection and so much more.

* An overview of our new grantees, including Dr. David Auerbach, recipient of The CURE Epilepsy Cameron Boyce SUDEP Research Award for his efforts in SUDEP research and intervention.

* A recap of events that helped sustain our work and the incredible donors and volunteers who made it possible.

Our path to a cure is truly a marathon, not a sprint. But we endeavor each and every day with unrelenting commitment to fund research that will lead to cures. We promise not to stop until we achieve our shared vision: a world without epilepsy.

Through research there is hope.

With sincerest gratitude,


Beth Lewin Dean, CEO
CURE Epilepsy
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]

============================================================
Copyright © 2022 CURE Epilepsy, All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.

Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
CURE Epilepsy . 420 Wabash Ave, Ste 650 . Chicago, IL 60611 . USA
Screenshot of the email generated on import

Message Analysis